454 filings
Page 5 of 23
424B5
2u6h5m rgvriqz
23 Mar 22
Prospectus supplement for primary offering
5:21pm
6-K
iolcdk
9 Feb 22
Purple Biotech Reports Second Half and Full-Year 2021 Financial Results
7:00am
6-K
v7v3nkohu6w
4 Feb 22
Purple Biotech Issues Letter to Shareholders
8:31am
6-K
hn1bjn7d v0mep
6 Jan 22
Purple Biotech Appoints Life Sciences Industry Investor Ori Hershkovitz to its Board of Directors
7:31am
6-K
acfr s2id
29 Dec 21
Current report (foreign)
4:22pm
6-K
gra7973
22 Dec 21
Report of Foreign Private Issuer
4:10pm
6-K
at2dx3y 2h179
9 Dec 21
Purple Biotech Appoints Senior Business Development Executive Fabien Sebille as Chief Business Officer
7:30am
6-K
j691dsyx5fa
6 Dec 21
Report of Foreign Private Issuer
7:30am
6-K
uw4zf
16 Nov 21
Report of Foreign Private Issuer
4:10pm
6-K
p0mzrjnqwd51zlrfiw1
10 Nov 21
Notice of Annual General Meeting of Shareholders
4:45pm
6-K/A
xd9h5
9 Nov 21
Current report (foreign) (amended)
6:10am
6-K
b2n04ddu 1wpwiuxp0vp
4 Nov 21
Report of Foreign Private Issuer
8:29am
6-K
5tiy22xtw8rwa
26 Oct 21
Report of Foreign Private Issuer
8:27am
6-K
08g nn8sqsu9mvi2m
22 Oct 21
Research Highlights Underlying the IRS1 Phosphorylation Status as a Memory Mechanism that Modulates Cellular Non-Genetic Resistance to Drug Therapy
6:02am
6-K
0lgwiymrlfdgg 4e9wzp
14 Oct 21
Report of Foreign Private Issuer
6:31am
6-K
kou1is 4hdxk1y6
8 Oct 21
Report of Foreign Private Issuer
6:28am
6-K
cxv8pwooovl2
13 Sep 21
Report of Foreign Private Issuer
7:02am
6-K
busgrn2gd81s alt
5 Aug 21
Purple Biotech Provides Corporate Update and Reports First Half 2021 Financial Results
8:33am
6-K
trhhj3o
9 Jun 21
Report of Foreign Private Issuer
5:06pm